Find Nitrofurazone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

3 RELATED EXCIPIENT COMPANIES

13EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Nitrofural, 59-87-0, Furacilin, Furacin, Furacillin, Actin-n
Molecular Formula
C6H6N4O4
Molecular Weight
198.14  g/mol
InChI Key
IAIWVQXQOWNYOU-FPYGCLRLSA-N
FDA UNII
X8XI70B5Z6

Nitrofurazone
A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial WOUNDS AND INJURIES and skin infections. Nitrofurazone has also been administered orally in the treatment of TRYPANOSOMIASIS.
1 2D Structure

Nitrofurazone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(E)-(5-nitrofuran-2-yl)methylideneamino]urea
2.1.2 InChI
InChI=1S/C6H6N4O4/c7-6(11)9-8-3-4-1-2-5(14-4)10(12)13/h1-3H,(H3,7,9,11)/b8-3+
2.1.3 InChI Key
IAIWVQXQOWNYOU-FPYGCLRLSA-N
2.1.4 Canonical SMILES
C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N
2.1.5 Isomeric SMILES
C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N
2.2 Other Identifiers
2.2.1 UNII
X8XI70B5Z6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Furacilin

2. Furacillin

3. Furacin

4. Nitrofural

5. Nitrofurazone, Calcium (2:1) Salt

2.3.2 Depositor-Supplied Synonyms

1. Nitrofural

2. 59-87-0

3. Furacilin

4. Furacin

5. Furacillin

6. Actin-n

7. 5-nitro-2-furaldehyde Semicarbazone

8. Aldomycin

9. Furacine

10. Furaldon

11. Nifuzon

12. Babrocid

13. Chemofuran

14. Furacinetten

15. Furacoccid

16. Furacycline

17. Furaplast

18. Furaziline

19. Furazone

20. Mastofuran

21. Monafuracin

22. Nitrofurazan

23. Nitrozone

24. Otofuran

25. Alfucin

26. Amifur

27. Furesol

28. Mammex

29. Nefco

30. Furazol W

31. 5-nitrofurfural Semicarbazone

32. Becafurazone

33. Biofuracina

34. Dermofural

35. Furametral

36. Furaseptyl

37. Furatsilin

38. Fuvacillin

39. Monafuracis

40. Monofuracin

41. Nitrofurol

42. Biofurea

43. Cocafurin

44. Coxistat

45. Dynazone

46. Eldezol

47. Fedacin

48. Flavazone

49. Fracine

50. Furacort

51. Furaderm

52. Furagent

53. Furalone

54. Furaskin

55. Furazin

56. Furazina

57. Furazyme

58. Furfurin

59. Furosem

60. Hemofuran

61. Ibiofural

62. Nifucin

63. Nifurid

64. Otofural

65. Sanfuran

66. Vabrocid

67. Vadrocid

68. Yatrocin

69. Chixin

70. 5-nitrofurazone

71. Furan-ofteno

72. Spray-dermis

73. Spray-foral

74. Furacin-hc

75. Nitrofuralum

76. Eldezol F-6

77. Furacilinum

78. Nitrofurane

79. (5-nitro-2-furfurylidenamino)urea

80. Furacin-e

81. Nitrofuraldehyde Semicarbazone

82. 5-nitrofuraldehyde Semicarbazide

83. Usaf Ea-4

84. Rivafurazon

85. Fura-septin

86. Veterinary Nitrofurazone

87. Nsc-2100

88. Nitrofuran (bactericide)

89. Nf-7

90. 6-nitrofuraldehyde Semicarbazide

91. Nitrofural [inn]

92. 5-nitro-2-furfural Semicarbazone

93. 1-(5-nitro-2-furfurylidene)semicarbazide

94. 5-nitrofuran-2-aldehyde Semicarbazone

95. 5-nitro-2-furfuraldehyde Semicarbazone

96. Nci-c56064

97. 5-nitro-2-furancarboxaldehyde Semicarbazone

98. Semikarbazon 5-nitrofurfuralu

99. Nfz

100. Hydrazinecarboxamide, 2-[(5-nitro-2-furanyl)methylene]-

101. Nsc-1602

102. U-6421

103. 2-furaldehyde, 5-nitro-, Semicarbazone

104. 5-nitrofuran-2-carbaldehyde Semicarbazone

105. 2-[(5-nitro-2-furanyl)methylene]-hydrazinecarboxamide

106. X8xi70b5z6

107. Nfs

108. 2-furancarboxaldehyde, 5-nitro-, Semicarbazone

109. Nsc1602

110. Nsc2100

111. [(e)-(5-nitrofuran-2-yl)methylideneamino]urea

112. Component Of Furea

113. (5-nitro-2-furfurylideneamino)urea

114. Nitrofural (inn)

115. Component Of Furadex

116. 2-[(5-nitro-2-furanyl)methylene]hydrazinecarboxamide

117. Component Of Furacort

118. 112574-44-4

119. Hydrazinecarboxamide, 2-((5-nitro-2-furanyl)methylene)-

120. Ncgc00090686-04

121. Ncgc00090686-07

122. Nitrofurazonum

123. Dsstox_cid_944

124. Dsstox_rid_75881

125. Dsstox_gsid_20944

126. 2-((5-nitrofuran-2-yl)methylene)hydrazinecarboxamide

127. Wln: T5oj Bnw E1unmvz

128. (2e)-2-[(5-nitrofuran-2-yl)methylidene]hydrazinecarboxamide

129. Dymazone

130. Furalcyn

131. Acutol

132. 2-furancarboxaldehyde, Semicarbazone

133. Rivopon-5

134. (e)-2-((5-nitrofuran-2-yl)methylene)hydrazinecarboxamide

135. Sr-05000002027

136. Mfcd00003225

137. 2-((5-nitro-2-furanyl)methylene)hydrazinecarboxamide

138. Nitrofuralum [inn-latin]

139. Chebi:44368

140. Unii-x8xi70b5z6

141. Ccris 1195

142. Nitrofurazone [usp:inn:ban]

143. Nfz Mix

144. Hsdb 3136

145. Cas-59-87-0

146. Nsc 1602

147. Nsc 2100

148. Prestwick_806

149. 2-[(5-nitro-2-furyl)methylene]hydrazinecarboxamide

150. Einecs 200-443-1

151. Furacin (tn)

152. 2((5-nitro-2-furanyl)methylene)hydrazinecarboxamide

153. Nitrofurazone (usp)

154. Semikarbazon 5-nitrofurfuralu [polish]

155. Brn 0086403

156. Ai3-17333

157. [(e)-(5-nitro-2-furyl)methyleneamino]urea

158. Prestwick2_000492

159. Prestwick3_000492

160. Spectrum5_001160

161. Nitrofural [iarc]

162. Nitrofurazone (nitrofural)

163. Nitrofurazone [mi]

164. Chembl869

165. Nitrofural [who-dd]

166. Nitrofurazone [hsdb]

167. Nitrofurazone [inci]

168. Schembl25416

169. Schembl25417

170. Bspbio_000383

171. Bspbio_002075

172. Nitrofurazone [vandf]

173. Mls002153843

174. Nitrofurazone [mart.]

175. Spectrum1500434

176. Nitrofurazone [usp-rs]

177. Bpbio1_000423

178. Component Of Furea (salt/mix)

179. Component Of Furadex (salt/mix)

180. Hms502g20

181. Nitrofural [ep Monograph]

182. (e)-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide

183. Hms1569d05

184. Hms1920b04

185. Hms2091j04

186. Hms2096d05

187. Hms3713d05

188. Nitrofurazone [green Book]

189. Pharmakon1600-01500434

190. Nitrofurazone [orange Book]

191. Hy-b0226

192. Zinc4802968

193. Tox21_110997

194. Tox21_202988

195. Tox21_400035

196. Bdbm50420350

197. Ccg-39642

198. Nitrofurazone [usp Monograph]

199. Nsc757244

200. S1644

201. Stk741625

202. 1-(5-nitrofurfurylidene)semicarbazide

203. 5-nitro-2-furaldehyde, Semicarbazone

204. 5-nitro-2-furfurylidene Semicarbazone

205. Akos000304771

206. Tox21_110997_1

207. Db00336

208. Nsc-757244

209. Idi1_000778

210. Ncgc00090686-01

211. Ncgc00090686-02

212. Ncgc00090686-03

213. Ncgc00090686-05

214. Ncgc00090686-06

215. Ncgc00090686-08

216. Ncgc00090686-11

217. Ncgc00260533-01

218. Nitrofurazone 100 Microg/ml In Methanol

219. Ac-10331

220. Bs-42205

221. Semioxamazide, 1-(5-nitrofurfurylidene)-

222. Smr000059012

223. Sbi-0051458.p003

224. Ab00373885

225. N0200

226. C08042

227. D00862

228. Ab00373885-04

229. Ab00373885_05

230. Ab00373885_06

231. Structure Of 5-nitro-2-furaldehyde-semicarbazone

232. [(e)-[(5-nitrofuran-2-yl)methylidene]amino]urea

233. Q-201480

234. Sr-05000002027-1

235. Sr-05000002027-3

236. Brd-k79092138-001-05-2

237. Brd-k79092138-001-06-0

238. 5-nitro-2-furaldehyde Semicarbazone, >=97.0% (hplc)

239. Nitrofural, European Pharmacopoeia (ep) Reference Standard

240. Hydrazinecarboxamide, 2-((5-nitro-2-furanyl)methylene)

241. Nitrofurazone, United States Pharmacopeia (usp) Reference Standard

242. Nitrofural For Peak Identification, European Pharmacopoeia (ep) Reference Standard

243. Nitrofurazone Solution, 100 Mug/ml In Acetonitrile, Vetranal(tm), Analytical Standard

244. Nitrofurazone, Pharmaceutical Secondary Standard; Certified Reference Material

2.4 Create Date
2005-07-10
3 Chemical and Physical Properties
Molecular Weight 198.14 g/mol
Molecular Formula C6H6N4O4
XLogP30.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass198.03890469 g/mol
Monoisotopic Mass198.03890469 g/mol
Topological Polar Surface Area126 Ų
Heavy Atom Count14
Formal Charge0
Complexity261
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Anti-Infective Agents, Local; Anti-Infective Agents, Urinary; Trypanocidal Agents

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


/NITROFURAZONE/ IS BACTERICIDAL FOR MANY GRAM POSITIVE & GRAM NEGATIVE ORGANISMS PRESENT IN SURFACE INFECTIONS ... IT HAS BEEN USED TOPICALLY TO TREAT INFECTIONS OF SKIN & MUCOUS MEMBRANES.

American Medical Association, AMA Department of Drugs. AMA Drug Evaluations. 4th ed. Chicago: American Medical Association, 1980., p. 1026


NITROFURAZONE MAY BE TRIED IN ... /LATE-STAGE TRYPANOSOMIASIS/ WITH SOME CHANCE OF SUCCESS. SINGLE COURSE OF TREATMENT ... AT 6 HR INTERVALS FOR 1 WK. 3 COURSES MAY BE GIVEN WITH A WEEK'S REST BETWEEN EACH.

Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 1074


IT FINDS USE, ESP, IN TREATMENT OF 2ND & 3RD DEGREE BURNS & IN SKIN GRAFTING IN WHICH THERE ARE COMPLICATIONS FROM BACTERIAL INFECTIONS THAT ARE REFRACTORY TO USUAL DRUGS OF CHOICE BUT IN WHICH SENSITIVITY TO NITROFURAZONE IS DEMONSTRABLE. ... NITROFURAZONE IS USED IN MGMNT OF SUSCEPTIBLE INFECTIONS OF EYE, EAR, NOSE, URETHRA & VAGINA. ... /IT/ RETAINS ITS ANTIBACTERIAL ACTIVITY IN BLOOD, SERUM & PUS; PHAGOCYTOSIS IS NOT INHIBITED & NITROFURAZONE DOES NOT INTERFERE WITH HEALING.

Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 1105


For more Therapeutic Uses (Complete) data for NITROFURAZONE (14 total), please visit the HSDB record page.


4.2 Drug Warning

... /TREATMENT AS IN LATE-STAGE TRYPANOSOMIASIS/ IS UNSUITABLE FOR FEBRILE OR DEBILITATED PATIENTS. ... IT PRODUCES HEMOLYTIC ANEMIA IN PATIENTS WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.

Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 1074


WHEN USED TOPICALLY IN EAR ... /NITROFURAZONE/ MAY PRODUCE CUTANEOUS SENSITIVITY REACTIONS. ... THIS TYPE OF REACTION ... FREQUENTLY MIMICS DISEASE BEING TREATED. ... /THIS DRUG REACTION/ CAN USUALLY BE RECOGNIZED BECAUSE THE INFLAMMATORY PROCESS BEGINS TO SPREAD TO LOBULE OF EAR & INFECTION DOES NOT RESPOND TO TREATMENT.

American Medical Association, AMA Department of Drugs, AMA Drug Evaluations. 3rd ed. Littleton, Massachusetts: PSG Publishing Co., Inc., 1977., p. 1000


... STRAINS OF PSEUDOMONAS & PROTEUS ARE OFTEN RESISTANT.

American Medical Association, AMA Department of Drugs. AMA Drug Evaluations. 4th ed. Chicago: American Medical Association, 1980., p. 1026


IT HAS NOT YET BEEN SHOWN TO BE USEFUL IN TREATMENT OF MINOR BURNS, WOUNDS, OR CUTANEOUS ULCERS WHICH ARE INFECTED. IT IS PROBABLY NOT EFFECTIVE IN TREATMENT OF PYODERMA. ... APPROX 0.5-2% OF PATIENTS BECOME SENSITIZED TO DRUG, SOMETIMES WITHIN 5 DAYS OF INITIATION OF TREATMENT. ... FOR ALL NITROFURAZONE DOSAGE FORMS, AVOID EXPOSURE AT ALL TIMES TO DIRECT SUNLIGHT, EXCESSIVE HEAT & ALKALINE MATERIALS.

Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 1105


For more Drug Warnings (Complete) data for NITROFURAZONE (8 total), please visit the HSDB record page.


4.3 Drug Indication

For the treatment of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Nitrofurazone is a topical antibacterial agent indicated as an adjunctive therapy for second and third degree burns when resistance to other agents is a real or potential problem. Nitrofurazone is also indicated in skin grafting when bacterial contamination may cause graft rejection or donor site infection, especially in hospitals with a history of resistant bacteria.


5.2 MeSH Pharmacological Classification

Anti-Infective Agents

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)


5.3 ATC Code

B - Blood and blood forming organs

B05 - Blood substitutes and perfusion solutions

B05C - Irrigating solutions

B05CA - Antiinfectives

B05CA03 - Nitrofural


D - Dermatologicals

D08 - Antiseptics and disinfectants

D08A - Antiseptics and disinfectants

D08AF - Nitrofuran derivatives

D08AF01 - Nitrofural


D - Dermatologicals

D09 - Medicated dressings

D09A - Medicated dressings

D09AA - Medicated dressings with antiinfectives

D09AA03 - Nitrofural


P - Antiparasitic products, insecticides and repellents

P01 - Antiprotozoals

P01C - Agents against leishmaniasis and trypanosomiasis

P01CC - Nitrofuran derivatives

P01CC02 - Nitrofural


S - Sensory organs

S01 - Ophthalmologicals

S01A - Antiinfectives

S01AX - Other antiinfectives

S01AX04 - Nitrofural


S - Sensory organs

S02 - Otologicals

S02A - Antiinfectives

S02AA - Antiinfectives

S02AA02 - Nitrofural


5.4 Absorption, Distribution and Excretion

Absorption

Well absorbed.


ABOUT 1% OF (14)C WAS RECOVERED FROM URINE, FECES & BILE AS UNCHANGED 5-NITRO-2-FURALDEHYDE SEMICARBAZONE, SUGGESTING SUBSTANTIAL METABOLISM OF THIS SUBSTANCE IN RAT /AFTER ORAL DOSAGE OF 100 MG/KG/.

IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V7 177 (1974)


RATS DOSED WITH 100 MG/KG 5-NITRO-2-FURALDEHYDE SEMICARBAZONE- [FORMYL-(14)C] ... EXCRETED ABOUT 66%, 35% & 1% OF ACTIVITY IN URINE, FECES & IN RESPIRED AIR AS CO2, RESPECTIVELY, WITHIN 96 HR, & MAJORITY OF (14)C ACTIVITY WAS ELIMINATED WITHIN 48 HR. RECOVERY OF (14)C IN BILE WAS ABOUT 27% AFTER 48 HR.

IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V7 177 (1974)


IN RATS DOSED WITH 100 MG/KG, PLASMA LEVELS OF 4.5 MG/L ... WERE FOUND AFTER 4 HR, 34% OF WHICH WAS BOUND TO PROTEINS. RATS DOSED WITH 200 MG/KG ... EXCRETED ABOUT 4.6% IN URINE & 0.5% IN FECES WITHIN 48 HR. ORALLY ADMIN 5-NITRO-2-FURALDEHYDE SEMICARBAZONE WAS DETECTED IN CEREBROSPINAL FLUID OF DOGS WITHIN 2 HR.

IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V7 177 (1974)


5.5 Metabolism/Metabolites

Nitrofurans, including nitrofural, undergo metabolic reduction at the nitro group to generate reactive species which can covalently bind to cellular macromolecules (Polnaszek et al., 1984; Kutcher & McCalla, 1984; McCalla 1979; McCalla et al., 1975).


/NITROFURAZONE HAS/ BEEN SHOWN TO BE REDUCED BY ENZYMES & PREPN FROM MAMMALIAN LIVER. ... ISOLATION OF A HYDROXYLAMINE INTERMEDIATE IS NOT UNCOMMON IN IN VITRO STUDIES.

Testa, B. and P. Jenner. Drug Metabolism: Chemical & Biochemical Aspects. New York: Marcel Dekker, Inc., 1976., p. 123


The disposition of the antibiotic nitrofurazone was studied in the singlepass isolated perfused rat liver. Both the effects of the steady state level of drug and the composition of the perfusate were evaluated. The higher level (120 ug/ml) of nitrofurazone in a perfusion medium lacking the glutathione precursors, glycine, glutamic acid and cysteine, caused a marked increase in bile flow (from 1.01 + or - 0.07 to 2.33 + or - 1.07 ul/min/g), massiv biliary efflux of glutathione disulfide (from 0.55 + or - 0.07 to 60.6 + or - 25.4 nmol/min/g) and a sharp decline in the caval efflux of glutathione (to undetectable levels) and the tissue level of glutathione (from 5.74 + or - 0.20 to 2.68 + or - 0.13 umol/g). Even after the drug was discontinued, these parameters were not restored to control levels. The lower level (30 ug/ml) of nitrofurazone with or without amino acid supplementatio and the higher level with supplementation induced less dramatic effects. Using (35)S methionine, a new conjugated metabolite of nitrofurazone and glutathione was detected. The data suggest that the toxicity of the reactive oxygen species generated by the redox cycling of the nitro group and the reactive metabolites generated by further reduction of nitrofurazone can be mitigated by adequate glutathione levels, but that livers lacking sufficient glutathione to scavenge these reactive species may be damaged.

PMID:3358793 Hoener BA; Biochem Pharmacol 37 (8): 1629-36 (1988)


5.6 Biological Half-Life

5 hours


5.7 Mechanism of Action

The exact mechanism of action is unknown. Nitrofurazone inhibits several bacterial enzymes, especially those involved in the aerobic and anaerobic degradation of glucose and pyruvate. This activity is believed also to affect pyruvate dehydrogenase, citrate synthetase, malate dehydrogenase, glutathione reductase, and pyruvate decarboxylase.


MECHANISM OF ANTIBACTERIAL ACTION OF FURAN DERIV IS UNKNOWN, BUT IT IS PRESUMED THAT THE COMPD INTERFERES WITH ENZYMATIC PROCESSES ESSENTIAL TO BACTERIAL GROWTH. /FURAN DERIV/

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1003


The exact mechanism of action of nitrofurazone is not known. It appears, howeverthat the drug acts by inhibiting bacterial enzymes involved in carbohydrage metabolism. Oragnic matter (eg, blood pus, serum) and aminobenzoic acid (p-aminobenzoic acid) inhibit the antibacterial action of nitrofurazone.

McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 93. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1993 (Plus Supplements, 1993)., p. 2212


API SUPPLIERS

read-more
read-more

01

Chynops Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Chynops Pharma

02

Jinan Jinda Pharmaceutical Chemist...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

Jinan Jinda Pharmaceutical Chemist...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIO Partnering at JPM
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Minsheng Group Shaoxing Pharmaceut...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

Minsheng Group Shaoxing Pharmaceut...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIO Partnering at JPM
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Assia Chemical Industries Ltd

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

Assia Chemical Industries Ltd

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIO Partnering at JPM
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

HESS & CLARK INC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

HESS & CLARK INC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIO Partnering at JPM
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Livmore Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

07

Menadiona

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

Menadiona

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIO Partnering at JPM
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

08

Gurvey & Berry

Canada

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

09

Zhejiang Multinpharma

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM
Not Confirmed
arrow

Zhejiang Multinpharma

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIO Partnering at JPM
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Topical

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Lubricants & Glidants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Rheology Modifiers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Nitrofurazone Manufacturers

A Nitrofurazone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitrofurazone, including repackagers and relabelers. The FDA regulates Nitrofurazone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitrofurazone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Nitrofurazone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Nitrofurazone Suppliers

A Nitrofurazone supplier is an individual or a company that provides Nitrofurazone active pharmaceutical ingredient (API) or Nitrofurazone finished formulations upon request. The Nitrofurazone suppliers may include Nitrofurazone API manufacturers, exporters, distributors and traders.

click here to find a list of Nitrofurazone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Nitrofurazone USDMF

A Nitrofurazone DMF (Drug Master File) is a document detailing the whole manufacturing process of Nitrofurazone active pharmaceutical ingredient (API) in detail. Different forms of Nitrofurazone DMFs exist exist since differing nations have different regulations, such as Nitrofurazone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Nitrofurazone DMF submitted to regulatory agencies in the US is known as a USDMF. Nitrofurazone USDMF includes data on Nitrofurazone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nitrofurazone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Nitrofurazone suppliers with USDMF on PharmaCompass.

Nitrofurazone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nitrofurazone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Nitrofurazone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Nitrofurazone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Nitrofurazone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nitrofurazone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Nitrofurazone suppliers with NDC on PharmaCompass.

Nitrofurazone GMP

Nitrofurazone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Nitrofurazone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitrofurazone GMP manufacturer or Nitrofurazone GMP API supplier for your needs.

Nitrofurazone CoA

A Nitrofurazone CoA (Certificate of Analysis) is a formal document that attests to Nitrofurazone's compliance with Nitrofurazone specifications and serves as a tool for batch-level quality control.

Nitrofurazone CoA mostly includes findings from lab analyses of a specific batch. For each Nitrofurazone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Nitrofurazone may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitrofurazone EP), Nitrofurazone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitrofurazone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty